Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVS | Common Stock | Options Exercise | $2.19M | +21.4K | +34.86% | $102.26 | 82.7K | Feb 1, 2022 | Direct | |
transaction | CVS | Common Stock | Sale | -$2.28M | -21.4K | -25.85% | $106.50 | 61.3K | Feb 1, 2022 | Direct | F1 |
holding | CVS | Common Stock | 492 | Feb 1, 2022 | By Children's Trusts | ||||||
holding | CVS | Common Stock (restricted) | 5.83K | Feb 1, 2022 | Direct | ||||||
holding | CVS | Stock Unit | 29.9K | Feb 1, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVS | Stock Option | Options Exercise | $0 | -21.4K | -100% | $0.00* | 0 | Feb 1, 2022 | Common Stock | 21.4K | $102.26 | Direct | F2 |
holding | CVS | Stock Option | 27.4K | Feb 1, 2022 | Common Stock | 27.4K | $104.82 | Direct | F3 | |||||
holding | CVS | Stock Option | 32.9K | Feb 1, 2022 | Common Stock | 32.9K | $78.05 | Direct | F4 | |||||
holding | CVS | Stock Option | 22.5K | Feb 1, 2022 | Common Stock | 22.5K | $62.21 | Direct | F5 | |||||
holding | CVS | Stock Option | 70.7K | Feb 1, 2022 | Common Stock | 70.7K | $54.19 | Direct | F6 | |||||
holding | CVS | Stock Option | 141K | Feb 1, 2022 | Common Stock | 141K | $58.34 | Direct | F7, F8 | |||||
holding | CVS | Stock Option | 121K | Feb 1, 2022 | Common Stock | 121K | $74.30 | Direct | F9 | |||||
holding | CVS | Phantom Stock Credits | 557 | Feb 1, 2022 | Common Stock | 557 | $1.00 | Direct | F10, F11 |
Id | Content |
---|---|
F1 | All sales were effected pursuant to a Rule 10b5-1 plan. |
F2 | Option became exercisable in four equal annual installments, commencing 4/1/2016. |
F3 | Option became exercisable in four equal annual installments, commencing 4/1/2017. |
F4 | Option became exercisable in four equal annual installments, commencing 4/3/2018. |
F5 | Option became exercisable in four equal annual installments, commencing 4/1/2019. |
F6 | Option became exercisable in four equal annual installments, commencing 4/1/2020. |
F7 | The number of shares subject to the option were calculated using a 30-day average price. |
F8 | Option became exercisable in four equal annual installments, commencing 4/1/2021. |
F9 | Option becomes exercisable in four equal annual installments, commencing 4/1/2022. |
F10 | Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. |
F11 | Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. |